Therefore, we aimed to evaluate skeletal muscle changes in morphology, mitochondrial function and insulin signaling, in morbidly obese patients, and correlate them with NAFLD severity. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.